/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

XBIOTECH INC Share Price Today: Live Updates & Key Insights

XBIOTECH INC share price today is $2.34, up 0%. The stock opened at $2.375 against the previous close of $2.34, with an intraday high of $2.375 and low of $2.33.

XBIOTECH INC Share Price Chart

style
pb-0

XBIOTECH INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

XBIOTECH INC Share Price Performance

$2.34 0(0%) XBIT at 13 Mar 2026 03:56 PM Biotechnology
Lowest Today 2.33
Highest Today 2.375
Today’s Open 2.375
Prev. Close 2.34
52 Week High 3.62
52 Week Low 2.09
Day’s Range: Low 2.33 High 2.375
52-Week Range: Low 2.09 High 3.62
1 day return -
1 Week return -0.42
1 month return -4.87
3 month return -7.32
6 month return -13.65
1 year return -26.41
3 year return -29.51
5 year return -86.53
10 year return -

XBIOTECH INC Institutional Holdings

Millennium Management LLC 1.37

BlackRock Inc 0.99

Vanguard Group Inc 0.98

Geode Capital Management, LLC 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.66

RBF LLC 0.65

Morgan Stanley - Brokerage Accounts 0.40

Fidelity Extended Market Index 0.33

Bridgeway Capital Management, LLC 0.29

Northern Trust Corp 0.27

State Street Corp 0.22

Squarepoint Ops LLC 0.21

EA Bridgeway Omni Small-Cap Value ETF 0.20

Empowered Funds, LLC 0.20

Jane Street Group LLC 0.18

iShares Micro-Cap ETF 0.17

Dimensional Fund Advisors, Inc. 0.17

Bank of New York Mellon Corp 0.16

Bank of America Corp 0.16

Citadel Advisors Llc 0.14

Blackrock Extended Mkt Fund CF 0.12

Fidelity Total Market Index 0.12

Extended Equity Market Fund K 0.10

Qube Research & Technologies 0.10

Connor Clark & Lunn Inv Mgmt Ltd 0.10

Bridgeway Ultra-Small Company 0.10

Fidelity Series Total Market Index 0.09

BNP Paribas Arbitrage, SA 0.09

Spartan Extended Market Index Pool F 0.08

The Goldman Sachs Group Inc 0.08

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - L 0.06

Fidelity Nasdaq Composite Index 0.06

Goldman Sachs Absolute Ret Trckr Instl 0.06

Spartan Total Market Index Pool G 0.05

NT Ext Equity Mkt Idx Fd - NL 0.04

Avantis US Small Cap Equity ETF 0.04

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Vanguard U.S. Eq Idx £ Acc 0.02

XBIOTECH INC Market Status

XBIOTECH INC Fundamentals

Market Cap 71.34 M

PB Ratio 0.427

PE Ratio 0.0

Enterprise Value -91.09 M

Total Assets 199.09 M

Volume 28817

XBIOTECH INC Company Financials

Annual Revenue FY23:300000 0.3M, FY22:4010000 4.0M, FY21:18394000 18.4M, FY20:43997000 44.0M, FY19:0 0.0M

Annual Profit FY23:284000 0.3M, FY22:3359000 3.4M, FY21:12574000 12.6M, FY20:9449000 9.4M, FY19:null 0.0M

Annual Net worth FY23:-23125000 -23.1M, FY22:-32900000 -32.9M, FY21:-17414000 -17.4M, FY20:-11221000 -11.2M, FY19:668629000 668.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:867000 0.9M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-427000 -0.4M, Q2/2025:-439000 -0.4M, Q1/2025:-442000 -0.4M, Q3/2024:null 0.0M, Q2/2024:-435000 -0.4M

Quarterly Net worth Q3/2025:-6008000 -6.0M, Q2/2025:-1756000 -1.8M, Q1/2025:-10884000 -10.9M, Q3/2024:-5015000 -5.0M, Q2/2024:-13006000 -13.0M

About XBIOTECH INC & investment objective

Company Information XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Organisation Biotechnology

Employees 88

Industry Biotechnology

CEO Dr. Sushma Shivaswamy Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow